Episode notes
This week, we have three interviews done during Life Sciences Baltics, which was held in Vilnius, Lithuania recently.
While we have more still to come, this week on the podcast we have conversations with Justinas Mačiulaitis, Keli Therapeutics’ founder and CEO; Arnas Karužas, CEO of Ligence; and Emilė Radytė, CEO and co-founder of Samphire Neuroscience.
Ligence
Ligence is a health‑tech startup using artificial intelligence to automate echocardiography.
Founded in 2019 by a team of medical doctors and engineers, the company’s flagship product, Ligence Heart, applies deep learning to 2D ultrasound images, automatically recognising views and performing cardiac measure ...
Keywords
biotechbiotechnologyLithuaniaLigenceKeli TherapeuticsMedTechSamphire